Best Researcher Award
Seyfullah Oktay Arslan
Ankara Yıldırım Beyazıt University, Türkiye
Seyfullah Oktay Arslan is a researcher at Ankara Yıldırım Beyazıt University, Türkiye[1]. He is nominated for the Best Researcher Award at International Academic Achievements & Awards.
Abstract
This article summarizes the scholarly profile of Seyfullah Oktay Arslan, based on publicly available bibliographic records. It outlines his research focus, recent publications, citation indicators and suitability for the Best Researcher Award [1][2].
Keywords
Best Researcher Award, Seyfullah Oktay Arslan, Ankara Yıldırım Beyazıt University, Environmental and Sustainable Materials, Scopus, h-index, airway pharmacology, natural compounds.
Introduction
Seyfullah Oktay Arslan is affiliated with Ankara Yıldırım Beyazıt University in Türkiye. His Scopus author profile (ID 7006604565) lists 44 documents, 973 citations and an h-index of 16 [1]. His ORCID record documents a continuing publication output across several journals [2].
Research Profile
His profile is categorized under Environmental and Sustainable Materials. His recent records, however, concentrate on experimental pharmacology and biomedical research. These include studies of airway smooth muscle responses, inflammation, neuroinflammation and natural bioactive compounds, often combining in vitro, in vivo and in silico methods [2].
Research Contributions
Recent contributions include work on cryptotanshinone, a natural terpenoid, and its bronchodilator potential. That study combines laboratory experiments with computational analysis [3]. Further work examines thymoquinone in an amyloid-beta-induced rat model of Alzheimer’s disease, reporting effects on cognitive impairment and neuroinflammation [4]. A 2026 article reviews cannabinoid CB2 receptors in allergic asthma and considers a possible role for the TRPV1 receptor [5].
Publications
Selected recent publications include:
- Cryptotanshinone as a Multi-Target Natural Terpenoid with Bronchodilator Potential, Molecules, 2026 [3].
- Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model, Brain Research, 2025 [4].
- Targeting Cannabinoid CB2 Receptors to Attenuate Airway Inflammation, Recent Advances in Inflammation & Allergy Drug Discovery, 2026 [5].
- Highly Brominated Quinolines: Synthesis, Characterization, and Anticancer Activities, Chemical Biology & Drug Design, 2025.
- A 2026 article in International Immunopharmacology (DOI: 10.1016/j.intimp.2026.117556).
Research Impact
With 973 citations across 44 documents and an h-index of 16, his Scopus record indicates sustained scholarly engagement [1]. His recent articles appear in peer-reviewed journals in pharmacology, neuroscience, immunology and medicinal chemistry.
Award Suitability
His nomination for the Best Researcher Award at International Academic Achievements & Awards rests on several factors: a verifiable publication record, collaborative authorship, citation indicators and consistent recent output. The selection of any recipient remains with the awarding committee.
Conclusion
Seyfullah Oktay Arslan has built a sustained research record at Ankara Yıldırım Beyazıt University. His publications and citation metrics support his consideration for the Best Researcher Award [1][3].
External Links
References
- Elsevier. (n.d.). Scopus author details: Seyfullah Oktay Arslan, Author ID 7006604565. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7006604565
- ORCID. (n.d.). Seyfullah Oktay Arslan (ORCID iD 0000-0001-9328-9373). ORCID.
https://orcid.org/0000-0001-9328-9373
- Rodwan, N. S., Koc Nas, A., Cam Ozunlu, S. A., Uysal, F., Celik, M. Z., Kara, H., & Arslan, S. O. (2026). Cryptotanshinone as a multi-target natural terpenoid with bronchodilator potential: Insights from integrated in vitro and in silico studies. Molecules, 31(12), 2122.
https://doi.org/10.3390/molecules31122122
- Çam Özünlü, S. A., Uysal, F., Tatlı Doğan, H., Parlar, A., Çetinkaya, A., & Arslan, S. O. (2025). Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer’s disease. Brain Research.
https://doi.org/10.1016/j.brainres.2025.149918
- Uysal, F., Çam Özünlü, S. A., Alhirmizi, I. A. O., Koç, A., Arslan, S. O., & Yıldız, O. (2026). Targeting cannabinoid CB2 receptors to attenuate airway inflammation and hyperresponsiveness in allergic asthma: Does the TRPV1 receptor play a role? Recent Advances in Inflammation & Allergy Drug Discovery.
https://doi.org/10.2174/0127722708446555260329213550